Latest Funding News

Aurelia Metals Limited has reported a strong turnaround with a $48.9 million net profit for FY25, driven by operational progress at its Federation Mine and the approval of the Great Cobar Project. The company’s strategic focus on base metals growth and sustainability underpins its improved financial and safety performance.

Intelligent Monitoring Group reports robust FY2025 financials, completes a strategic acquisition, and issues new shares following warrant exercises, signaling a confident growth trajectory.

Felix Group Holdings Ltd has launched a capped $1 million Share Purchase Plan (SPP) offering eligible shareholders a discounted entry to support its strategic acquisition of Nexvia Pty Ltd and fuel growth initiatives. This retail-focused SPP complements a larger institutional placement as Felix aims to expand its enterprise software footprint.

Marimaca Copper Corp. has released a Definitive Feasibility Study for its Marimaca Oxide Deposit in Chile, highlighting a robust 13-year mine life, low capital intensity, and strong financial returns. The study confirms a maiden ore reserve and positions the project as a competitive copper producer with advanced permitting and financing underway.

Australian Clinical Labs delivered solid FY25 financial results with revenue up 6.4% and EBIT rising 8.7%, underpinned by operational efficiencies and strategic innovation. The company’s FY26 guidance signals continued growth amid evolving market conditions and government fee pressures.

Australian Clinical Labs reported robust FY25 financial results with revenue and earnings growth, alongside a strong dividend payout and positive outlook for FY26.

Felix Group Holdings has launched a $1 million Share Purchase Plan offering shares at a 3.7% discount to support its acquisition of Nexvia Pty Ltd and growth initiatives.

Fortescue Metals Group reported a robust FY25 with record iron ore shipments and strong profits, while advancing its green metal and decarbonisation initiatives. The company also provided solid FY26 guidance amid ongoing exploration and capital discipline.

29Metals has reported a robust turnaround in its half-year results, posting a $35 million net profit and significantly reducing debt, underpinned by operational improvements and insurance proceeds.

Holista Colltech has inked a binding supply and development agreement with US-based Regenerex Pharma to exclusively supply proprietary ovine collagen for advanced wound care products, targeting the lucrative US market initially with plans for global expansion.

Noumi Limited has posted a significant $150 million loss for the year ending June 2025, driven by non-cash charges and raising questions about its financial stability.

Firebrick Pharma has closed a $1.4 million placement to fund expansion of its Nasodine nasal spray in key international markets and advance new product development.